Home/Filings/4/0001209191-23-006037
4//SEC Filing

McManus Timothy M 4

Accession 0001209191-23-006037

CIK 0000860730other

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 8:02 PM ET

Size

13.0 KB

Accession

0001209191-23-006037

Insider Transaction Report

Form 4
Period: 2023-01-30
McManus Timothy M
Group President
Transactions
  • Sale

    Common Stock

    2023-01-30$254.05/sh7,800$1,981,60714,087.414 total
  • Sale

    Common Stock

    2023-01-30$254.60/sh100$25,46013,987.414 total
  • Award

    Stock Appreciation Right

    2023-01-30+17,05117,051 total
    Exercise: $253.30From: 2024-01-30Exp: 2033-01-30Common Stock (17,051 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.54 to $254.475, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.

Issuer

HCA Healthcare, Inc.

CIK 0000860730

Entity typeother

Related Parties

1
  • filerCIK 0001957740

Filing Metadata

Form type
4
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 8:02 PM ET
Size
13.0 KB